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1 Introduction
Diseases like cancer are a major leading cause of death in 
today’s world. Early detection is extremely important for 
effective and successful treatments of such diseases (Emery 
et al. 2014). Point-of-care biosensors can be used in early 
detection by providing low-cost, low-power and small plat-
forms, which are easily accessible at home site and usable 
without any complex sample handling or any kind of spe-
cial expertise (Soper et al. 2006; Wang 2006). Biosensor 
technologies offer various transduction mechanisms includ-
ing optical (Geng et al. 2014; Maharana et al. 2014; Ligler 
and Taitt 2008; Narsaiah et al. 2011) magnetic (Devkota 
et al. 2014; Li and Kosel 2014; Xie et al. 2011; Yoo et al. 
2011) and electrical (Dong et al. 2010; Pui et al. 2013; Guo 
2013; Buitrago et al. 2014; Chen et al. 2012) detection. 
Among these mechanisms, electrical based detection stands 
out as a strong candidate for point-of-care health appli-
cations since it offers simplicity, chip-integrability; and, 
moreover it is quite inclined to low-cost and low-power 
platforms.
Biosensors are divided mainly into two categories 
according to their transduction mechanisms: labeled and 
label-free detection. Labeled biosensors are less suitable 
for point-of-care health monitoring applications due to 
sample handling, time and cost issues; whereas label-free 
biosensors, allowing simple, fast, and low-cost detection, 
are more preferable (Daniels and Pourmand 2007).
Impedance spectroscopy is an electrical based technique 
for characterizing systems of interest. It offers advantages 
like label-free, low cost, low power requirement, miniatur-
izable, and chip-integrable detection platforms, which are 
extremely appealing for point-of-care and early disease 
detection applications. However, impedance spectroscopy 
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in ionic solutions is hampered by a charge layer called elec-
tric double layer. When two metal plates are immersed in 
a solution and a voltage is applied between them, ions in 
the solution start to accumulate near the plates, forming 
a diffusion layer. In addition, there is a layer of immobile 
ions on the plates forming the Stern layer. These two lay-
ers together are called as electrical double layer. Gouy-
Chapman model (Parsons 1990) can be used to understand 
the effect of this layer on electric field distribution between 
the plates. The model assumes that the ions behave as point 
charges and employs the Poisson-Boltzmann equation to 
predict electric field distribution in the solution. This model 
provides relatively good predictions for solutions with 
ionic strengths <0.2 Molar and for applied electrical volt-
ages below 50–80 mV (Butt et al. 2006). This model can 
be used in this work since the ionic strength is in the order 
of 10−7 M and applied rms voltage is 10 mV. According to 
this model, the electric field with respect to distance x from 
an electrode can be expressed as
Electric field decays exponentially with increasing dis-
tances from the electrode (Eq. 1) and most of the field 
decays in a region determined by the size of the electrical 
double layer (Fig. 1). The decaying constant λD is called 
Debye length.
Electrical double layer acts as a shield against the 
applied electric field. This causes a major problem for the 
biosensor applications since the electric field applied by 
the electrodes does not appear on the significant portion 
of the target medium. There are two ways of dealing with 
this problem, which are increasing the Debye length and 
decreasing the electrode separation distance.
Increasing Debye length is possible by decreasing the 
ionic strength of the solution. For water at 25 °C, Debye 
length is (Butt et al. 2006),
where C is the ionic strength. Debye length for human 
blood plasma is about 0.78 nm due to the high ionic (like 
Na+, K+, Cl−) content in it. This is a very short distance and 
thus, it is hardly possible to apply impedance spectroscopy 
in human blood as the sample medium. On the other hand, 
deionized (DI) water is a much better choice for obtain-
ing larger Debye lengths. DI water is simply water purified 
from its mineral ions such as sodium, calcium, iron, cop-
per, chloride and bromide. Thanks to this purification pro-
cess, ionic strength can be decreased down to 2 × 10−7 and 
thereby, Debye lengths as long as 760 nm (only 0.78 nm 
in human blood plasma) can be obtained. Using DI water 










effect of the undesired electrical double layer, however, the 
separation distance of the electrodes should also be in the 
order of Debye length to warrant electric field uniformity 
within the target medium.
Nanogap refers to the gap formed between the two elec-
trodes with the separation distance in the order of nanom-
eters. Nanogap concept, in addition to using DI water as the 
sample medium, enables all molecules filling the gap expe-
rience almost identical electrical conditions, thus producing 
more uniform sensitivity results. In addition to this, since 
even a single molecule can occupy a reasonable percent of 
the little volume inside the nanogap, nanogap biosensors 
can be extremely sensitive to DNA’s, proteins and other 
biological molecules, which are all in nanoscale. Therefore, 
the ability of shrinking measurement volumes to nanometer 
dimensions is also a motivating reason for using nanogap 
based impedance spectroscopy in detection of low amounts 
of target molecules.
Benefits of nanogap in impedance spectroscopy can be 
realized by nanogap devices. Numerous nanogap devices 
with various fabrication techniques have been reported pre-
viously (Chen et al. 2010; Yi et al. 2005; Gu et al. 2009; 
Nevill et al. 2005). These devices can be categorized as pla-
nar or vertical nanogap devices. Planar devices have been 
fabricated by techniques including lithography or chemical 
deposition. Although it has been reported that some out-
standing results can be obtained with these techniques, they 
are in general not suitable for high-throughput fabrication. 
On the other hand, vertical nanogap devices are formed by 
vertically situated electrodes. They are usually formed by 
incorporating nanometer height sacrificial layers between 
the electrodes. Nanogap is formed by removing the sacri-
ficial layer (Schlecht et al. 2007); though, some of it may 
be preferred to remain as a spacer between the electrodes 
(Ionescu-Zanetti et al. 2006; Im et al. 2007). Advantage of 
these devices is that they can use low-cost, mature thin film 
growth techniques for nanoscale height sacrificial layer. 
These versatile techniques offer great thickness uniformity 
and control in addition to cost effectiveness. Thus, verti-
cal nanogap devices have been preferred in nanogap based 
impedimetric biosensors.
In this work, a nanogap based impedimetric biosensor 
for streptavidin detection is demonstrated. Biotin-strepta-
vidin system was studied because of their known strong 
non-covalent interactions in nature (Dissociation constant 
Kd is on the order of ≈10−14 mol/L). We present design, 
fabrication, and surface functionalization of the biosen-
sor. The surfaces were characterized by scanning electron 
microscopy (SEM) and X-ray photoelectron spectros-
copy (XPS) analysis. Overall efficiency of the biosensor 
is analyzed by impedance measurements. Sensitivity tests 
showed that detection of various streptavidin concentra-
tions from 100 µg/mL to 10 ng/mL is possible. To the best 
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of our knowledge, this is the first nanogap based impedi-
metric sensor showing a ligand–protein binding. Reliability 
tests proved stable and repeatable operation of the sensors, 
which are essential for any biosensor platform.
2  Materials and methods
2.1  Design considerations
A vertical nanogap device structure is designed to detect 
impedimetric changes when target molecules are bound to 
the recognition elements. Recognition elements are placed 
on the dielectric layer in between. This dielectric layer 
functions as a separator for two electrodes, as well as a 
holder for receptor molecules (Fig. 2).
The measurement volume and the surface area of the 
recognition elements can be manipulated by the sensor 
geometry. The electrode geometry shown in Fig. 2d serves 
the purpose of increasing the percentage of the (target 
molecule sensing) nanogap area with respect to (insensi-
tive) dielectric material volume, which contributes con-
stant impedance to the overall impedance. The structure in 
Fig. 2c increases the ratio of sensor perimeter (proportional 
to nanogap volume) versus sensor area (proportional to 
dielectric volume) by about 145 times when compared to a 
square pad occupying the same area. In this design, fingers 
with high permittivity to area ratio comprise 89 % of the 
whole area.
2.2  Fabrication of nanogap devices
Nanogap devices were fabricated by consecutive depo-
sition of metal and dielectric layer stack of Cr(10 nm)/
Au(100 nm)/Cr(10 nm)/SiO2(200 nm)/Al2O3(40 nm)/
Cr(10 nm)/Au(120 nm) followed by a partial sacrificial 
etching step. Thin Cr layers are used to promote adhesion 
between Au and oxide layers. Cr and Au layers are depos-
ited by thermal evaporation. SiO2and Al2O3 layers were 
deposited by plasma-enhanced chemical vapor deposition 
(PECVD) and atomic layer deposition (ALD), respectively. 
Main aim of the thin alumina layer is to effectively passi-
vate the oxide surface by conformably coating the possible 
pin-holes formed during PECVD coating process. The top 
120-nm-thick Au layer is patterned using standard lift-off 
process. Using this Au layer as an etch mask, SiO2 + Al2O3 
layers are partially etched in diluted HF (hydrofluoric acid) 
solution such that nanogaps were formed at the edges of the 
electrodes. Formation of the nanogaps is verified by SEM 
images (Fig. 3).
2.3  Immobilization of biotin on the nanogap surface
For active biosensing model, the oxide layer was function-
alized by a surface modification procedure. Theaminopro-
pyltrimethoxysilane (APTS) functionalization procedure 
was used since it is a well-known, highly efficient sur-
face preparation procedure (Ahluwalia et al. 1992; Ulman 
1996). Prior to surface functionalization, the sample was 
cleaned thoroughly with acetone, 50 % methanol/toluene 
mix and 100 % toluene respectively (all purchased from 
Merck). APTS was purchased from Sigma-Aldrich and 5 % 
APTS (0.213 mM) solution was prepared in toluene. The 
cleaned sample was immersed into this solution at room 
temperature for about 5 h. This was followed by exhaustive 
toluene and methanol rinse and nitrogen blow-drying.
Following the surface functionalization, biotinylation 
process was started to fix biotin molecules to functional-
ize walls of the nanogap. The reaction between free car-
boxylate group of the biotin and free amine group of the 
APTS on the surface was performed by standard amide 
formation reaction (Ulman 1996; Acar et al. 2011). Bioti-
nylation solution was prepared by dissolving two equiva-
lents of biotin (purchased from Sigma-Aldrich), 1.95 
Fig. 1  Electric field intensity 
between the two electrodes in a 
solution
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equivalents of O-Benzotriazole-N,N,N′,N′-tetramethyl-
uronium-hexafluoro-phosphate (HBTU, purchased from 
ABCR), three equivalents of N,N-diisopropylethylamine 
(DIEA, purchased from Merck) in 30 mL dimethylforma-
mide (DMF, purchased from Sigma-Aldrich). This amount 
was sufficient to coat more than ten times the whole APTS 
on the substrate surface. HBTU and DIEA were used forthe 
activation of the carboxylate group of biotin for immo-
bilization on the surface. After washing with DMF, the 
samples were immersed into biotin solution at room tem-
perature for about 2 h. Then, the samples were rinsed with 
dichloromethane (DCM, purchased from Merck), ethanol, 
DDW (double distilled water) and blow-dried with nitro-
gen. Efficiency of the procedure was verified by XPSanaly-
sis. Presence of S atoms was used as an indicator of biotin 
molecules. Results verified that biotin molecules are pre-
sent only on the samples with SiO2 surface as expected.
Fig. 2  Operation principles and various views of the designed sensors
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The above protocol was performed only for once per 
sample and after the completion of these steps, sensor fabri-
cation is completed and sensors are ready for measurement.
2.4  Measurements: introduction of streptavidin
Measurement procedure starts with the introduction of 
streptavidin. Streptavidin was purchased from Sigma-
Aldrich and used in phospate-buffered saline solution 
(PBS, pH 7.4). PBS solution was prepared by dissolv-
ing 2 g of KCl, 80 g NaCl, 2.4 g of KH2PO4 and 14.4 g 
of K2HPO4 in 1000 mL of double distilled water (DDW) 
(all purchased from Merck). Streptavidin was prepared in 
different concentrations ranging from 100 µg/mL to 10 ng/
mL.
Streptavidin solution was introduced on the surface of 
the sample by a micropipette and incubated for 10 h. This 
duration is quite sufficient for streptavidin immobiliza-
tion to the walls in the nanogap and it can be shortened as 
well. During the incubation, the sample was preserved in 
a vacuum-sealed container to avoid evaporation. This was 
followed by rinsing the sample thoroughly using DI water 
and blow drying with nitrogen. This step is also helpful for 
improved selectivity since molecules attached to the sur-
face of the nanogap through nonspecificbinding would be 
removed after this step.
2.5  Measurements: electrical characterization
A parameter analyzer capable of low-frequency impedance 
measurements (Keithley 4200-SCS with 4200-CVU) and a 
manual DC-probe station (Cascade PM-5) are used. Capac-
itance measurements are performed within the frequency 
range of 1–100 kHz. The frequency sweep is performed at 
19 frequencies (1, 2,…, 10, 20, … 100). Applied ac voltage 
signal amplitude is 10 mVrms.
The sample is mounted on the vacuum chuck of probe 
station, and by the help of micromanipulators, micro-nee-
dle tips are precisely positioned and connected to the upper 
and bottom electrode pads for electrical connection to the 
parameter analyzer. Open circuit and short circuit calibra-
tion is performed prior to the measurements. All measure-
ments were conducted in DI water after DIwater rinse and 
nitrogen dry for repeatability.
3  Results and discussion
Electrical measurements were performed before and after 
the introduction of streptavidin and compared with each 
other to detect presence of streptavidin in the nanogap. In 
order to get capacitance values out of the measured imped-
ance values, designed biosensor structure was modeled 
with an equivalent circuit model (Fig. 4). Since two elec-
trodes are separated by a distance on the order of Debye 
length (about 760 nm for DI water), the complex effect of 
electrical double layer is eliminated in this design. Thus, 
the overall nanogap is modeled with only its capacitance 
and resistance connected in parallel.
Cp values were extracted from impedance values by 
using the model in Fig. 4b. Cp changes with respect to 
frequency of the applied signal were observed for the 
five different streptavidin concentrations. The measured 
capacitance versus frequency curves before and after the 
application of streptavidin are shown in Fig. 5 for differ-
ent concentrations of streptavidin solutions. Measured 
capacitances for all frequencies decrease after streptavi-
din addition since the streptavidin proteins have lower 
dielectric constant than the water molecules they displaced 
(ɛDI-water ≅ 80, ɛstreptavidin ≅ 2). It is observed that for the 
highest streptavidin concentration (100 µg/mL) maximal 
capacitance change is approximately 1.93 nF, whereas this 
is 475 pF for the lowest streptavidin concentration (10 ng/
mL). Therefore, the biosensor can detect the presence of 
streptavidin within this range. Upper and lower limits of 
detection are out of the concentration range considered in 
this work and dynamic range covers the whole concentra-
tion range of 100 µg/mL to 10 ng/mL. However extraction 
of sensitivity to streptavidin concentration is hindered due 
to difference in “pre-streptavidin” states (“pre-streptavi-
din” plots are not the same for all cases). This is because 
the measurements were performed on different sensors of 
the same wafer and PECVD-coated SiO2 dielectric film is 
non-uniform. Figure 5f shows the percentage change in the 
measured capacitance before and after the application of 
Fig. 3  A cross sectional scanning electron microscope image of the 
fabricated nanogap biosensors (before surface functionalization)
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streptavidin solution. At 10 kHz measurements, the mini-
mum change in the measured capacitance is above 10 % for 
concentration range of 100 µg/mL to 10 ng/mL. The change 
in C with concentration of streptavidin proteins at 10 kHz 
are better separated with respect to 50 kHz measurement. 
However, for streptavidin concentration quantification pur-
poses, a more linear change is desired. This requires further 
analysis on almost identical sensors. Looking at the current 
results, it is not possible to have a conclusion on sensitivity 
with respect to streptavidin concentration.
Measurement results are consistent with the theoretical 
estimations. Using the parallel plate capacitor model with 
undercut length taken as 500 nm (Fig. 3), Cp is estimated to 
be 2.22 nF. This is very close to the observed capacitance 
values in Fig. 5, especially at high frequencies. Although 
nanogap design and DI water measurement medium are 
preferred to avoid electrical double layer; it seems that this 
effect is not completely eliminated. However, at higher 
frequencies, the effect of electrical double layer is less 
significant due to ionic relaxation (ions cannot respond 
quickly enough to form electrical double layer) and thus 
parallel plate model, which assumes no electrical double 
layer, seems to fit better to the measured results. Neverthe-
less, high frequencies are not preferable since capacitance 
change is very small.
The most significant capacitance variations were 
observed at around 10 kHz. While earlier reports on imped-
imetric biosensors are generally limited to very high fre-
quencies (>100 MHz) of operation with relatively expen-
sive instruments to eliminate the parasitic contribution of 
the ions (electrical double layer) in the solution, our current 
design utilizing the nanogap configuration can be operated 
at orders of magnitude lower frequencies. Required meas-
urement equipments are relatively low cost when compared 
to their RF counterparts such as a network analyzer. More-
over, at GHz frequencies, even the metal lines carrying the 
signal may become problematic due to inductive losses. 
Thus, special care is required for RF signal handling as 
well as impedance matching issues to avoid signal reflec-
tions. Not only low frequency sensors are easier to han-
dle, but also they are more amenable to chip-integration, 
which is especially important for point-of-care biosensor 
applications.
Applied AC voltage signal amplitude is 10 mVrms. This 
is an advantage of impedance spectroscopy over current–
voltage spectroscopy where DC voltage sweep up to sev-
eral volts are used. As far as biosensing applications are 
concerned, high voltages would damage the biological 
structures like proteins. Moreover, system may respond 
nonlinearly at resulting high electric fields and harmonics 
of the excitation frequency might be produced.
Reliability tests were performed for the verification of 
stability and repeatability. Stability tests were performed 
after biotinylation of sensors. The sample is mounted on the 
vacuum chuck and probed by micromanipulators. Shortly 
after starting Cp versus time measurement, DI water is 
introduced on the sample by a micropipette (Fig. 6a). Sig-
nal response is observed for about 20 min, which is a quite 
long duration considering point-of-care applications where 
single impedance measurement is enough and can be com-
pleted within a second after stabilization is satisfied. How-
ever, it is meaningful to test stability for long durations 
considering clinical applications, where constantly moni-
toring the concentration of target molecules with respect 
to time is required. Signal stabilization is satisfied shortly 
after the application of DI water around 1.67 nF within a 
tolerance band of ±0.03nF. Signal is sustained within this 
tolerance range during 20 min time intervals considered. 
Small changes in the capacitance might be due to non-static 
ionic distribution created by the rapidly changing electric 
field.
The response time was measured by analyzing the 
change in signal response during DI water application 
and observed to be <10 s (Fig. 6b). This is mainly the 
time for DI water filling the nanogap. Repeatability was 
tested by changing the measurement medium from air to 
Fig. 4  Equivalent circuit model 
for the nanogap biosensors in 
this work a Nanogap is modeled 
with a capacitor (C1 or C2) and 
resistor (R1 or R2) in parallel, 
whereas dielectric layer is mod-
eled with a capacitor (C3). b A 
more compact equivalent circuit 
obtained by combining the 
capacitors and resistors
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Fig. 5  a–e Capacitance (Cp) versus frequency (f) for different con-
centrations of streptavidin solution. For all concentrations, significant 
changes in the capacitances are observed after streptavidin proteins 
are bound to the biotin molecules. f Percentage change in the meas-
ured capacitance before and after the application of streptavidin solu-
tion at 10 and 50 kHz
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DI water (by wetting with a micropipette) and DI water 
to air (by drying with a nitrogen gun) (Fig. 6c). These 
tests were also performed on other sensors on the same 
wafer and similarly, stable and reproducible results were 
observed.
4  Conclusions
Here, we demonstrated nanogap based impedimetric sensor 
for streptavidin detection. Sensitivity tests revealed detec-
tion of various streptavidin concentrations from 100 µg/mL 
to as low as 10 ng/mL is possible. Reliability tests proved 
stable and repeatable operation of the sensors. Electrical 
double layer formed due to ions in the solution of inter-
est is problematic since it shields the applied electric field. 
Nanogap allows eliminating this problem at low frequen-
cies, which gives the opportunity of chip-integrality for 
point-of-care biosensors. Nanogap based biosensor struc-
ture has enabled minimizing the measurement volume and 
promising for low concentration target molecule detection. 
Measurement method is designed such that after the appli-
cation of target solution, DI water medium is used for 
obtaining electrical double layer free measurements. This 
is also beneficial in increasing the dielectric constant con-
trasts between the target molecules and medium of meas-
urement and thereby, improving sensitivity. Moreover, this 
measurement protocol includes DI water rinse step, which 
serves the purpose of selectivity by removing the unspe-
cifically bound molecules from the measurement medium. 
These biosensors are also appealing because they are oper-
ating at 10 mVrms and offer low-power platforms. The cur-
rent platform can be integrated with a microfluidic system 
and a low-cost commercial capacitance chip. This combi-
nation can offer novel and beneficial systems for the pur-
pose of point-of-care and early disease detection.
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